Proto-Oncogene Proteins c-bcl-6
"Proto-Oncogene Proteins c-bcl-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA-binding protein that contains an N-terminal BTB (POZ) DOMAIN and C-terminal CYS2-HIS2 ZINC FINGERS. It represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.
| Descriptor ID |
D051560
|
| MeSH Number(s) |
D12.776.260.660 D12.776.624.664.700.170 D12.776.930.715
|
| Concept/Terms |
Proto-Oncogene Proteins c-bcl-6- Proto-Oncogene Proteins c-bcl-6
- Proto Oncogene Proteins c bcl 6
- c-bcl-6, Proto-Oncogene Proteins
- B-Cell Lymphoma 6 Protein
- B Cell Lymphoma 6 Protein
- Zinc Finger Protein 51
- c-bcl-6 Protein
- c bcl 6 Protein
- bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, bcl-6
- bcl 6 Proto Oncogene Proteins
- c-bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-bcl-6
- c bcl 6 Proto Oncogene Proteins
- Proto-Oncogene Protein bcl-6
- Proto Oncogene Protein bcl 6
- bcl-6, Proto-Oncogene Protein
- Proto-Oncogene Protein c-bcl-6
- Proto Oncogene Protein c bcl 6
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-bcl-6".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-bcl-6".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-bcl-6" by people in this website by year, and whether "Proto-Oncogene Proteins c-bcl-6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-bcl-6" by people in Profiles.
-
DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure. Signal Transduct Target Ther. 2024 05 24; 9(1):127.
-
Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells. Immunity. 2019 07 16; 51(1):185-197.e6.
-
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease. Blood. 2019 01 03; 133(1):94-99.
-
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes. Mol Cell. 2018 06 07; 70(5):825-841.e6.
-
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 2016 04 28; 127(17):2144-54.
-
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol. 2016 Feb; 40(2):253-61.
-
Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol. 2014 Sep; 166(6):891-901.
-
IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol. 2013 Feb; 43(2):468-79.
-
ADAM10 regulates transcription factor expression required for plasma cell function. PLoS One. 2012; 7(8):e42694.
-
Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem. 2011 Aug 19; 286(33):28833-28843.